Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Cantilevered probe detector with piezoelectric element
Method and apparatus for controlling cardiac resynchronization therapy using cardiac impedance
Methods and systems for improved engine speed control during engine starting
Device and method for adjusting a chrominance signal based on an edge strength
Manufactured product configuration
System and method for solving connection violations
Method and apparatus for executing load distributed printing
  Randomly Featured Patents
Trotline reel
Interspace irrigator
Model gun with automatic bullet supplying mechanism
Vacuum lift foam filled casting system
Series diode X-ray source
Ear coupler
Easily removed sleeve and bulk containers and method incorporating same
Method and machine for levelling concrete when casting large concrete areas
Wheel guard for two-wheeled vehicles
Inhibiting popcorn polymer growth